Grants & Projects per year
Personal profile
Fingerprint
Dive into the research topics where Nicholas Smith is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The Center for Phage Pharmaceuticals (Phage Pharm)
Smith, N. (PI)
National Institute of Allergy & Infectious Disease
04/1/26 → 07/31/26
Project: Research
-
Pharmacokinetics and Pharmacodynamics of Mechanistically Aware Phage Cocktails
Smith, N. (PI), Chen, L. (CoI), Morse, E. (CoI) & Wood, T. (CoI)
National Institute of Allergy & Infectious Disease
07/1/24 → 07/31/29
Project: Research
-
Novel Combination Therapies to Combat Hypermutable Carbapenem-Resistant P. aeruginosa
Tsuji, B. (PI), Russo, T. (CoI), Smith, N. (CoI) & Sutton, M. (CoI)
National Institute of Allergy & Infectious Disease
05/24/22 → 03/25/26
Project: Research
-
Age and Race Influences on Immunosuppression after Renal Transplant
Tornatore-Morse, K. (PI), Mager, D. (CoI), Murray, B. (CoI), Smith, N. (CoI), Sprowl, J. (CoI), Wilding, G. (CoI) & Venuto, R. C. (CoI)
08/15/18 → 06/30/26
Project: Research
-
Ceftazidime/avibactam and aztreonam combined with an aminoglycoside combat metallo-β-lactamase-producing Klebsiella pneumoniae
Karunanidhi, A., Singh, N., Watkins, J. V., Smith, N. M., Zang, Y., Shan, X., Espinoza, G., Li, J., Lang, Y., Bulitta, J. B. & Bulman, Z. P., Mar 2026, In: Antimicrobial Agents and Chemotherapy. 70, 3Research output: Contribution to journal › Article › peer-review
Open Access -
Enhanced Clearance of HIV-1 Broadly Neutralizing Antibody VRC07-523-LS During Viremia: Influences on Trial Design and Analysis
Smith, N. M., Ho, B. M., Bar, K. J., Gama, L., Dziubla, G., Koup, R. A., Pensiero, M., Serebryannyy, L., Caskey, M., Wilkin, T. J., Wood, T. D., Morse, G. D., Venuto, C. S., Cha, R. & Ma, Q., Feb 2026, In: Clinical and Translational Science. 19, 2, e70488.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Pharmacodynamic individualization of phage therapy against a KPC-5-producing Pseudomonas aeruginosa
Nguyen, T. D., Sanborn, J. T., Ho, B. M., Luong, T., Wood, T. D., Chen, L., Roach, D. R. & Smith, N. M., Feb 1 2026, In: JAC-Antimicrobial Resistance. 8, 1, dlaf257.Research output: Contribution to journal › Article › peer-review
Open Access -
Whole-body distribution of three Pseudomonas phages characterized by a translational physiologically based pharmacokinetic model
Echterhof, A., Dharmaraj, T., Blankenberg, P., Targ, B., Nguyen, T. D., Bollyky, P. L., Smith, N. M. & Blankenberg, F. G., Jan 2026, In: Antimicrobial Agents and Chemotherapy. 70, 1Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Combatting mobile colistin-resistant (MCR), metallo-β-lactamase (MBL)-producing Klebsiella pneumoniae persisters
Klem, J. F., Kaur, J. N., Liu, Y., Boissonneault, K. R., Kapoor, S., Holden, P. N., Chen, A., Zhao, Y., Chen, L., Smith, N. M. & Tsuji, B. T., Aug 1 2025, In: JAC-Antimicrobial Resistance. 7, 4, dlaf132.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations